NK 1.1+ T cell: A two-faced lymphocyte in immune modulation of the IL-4/IFN-γ paradigm

Journal of Clinical Immunology

Volumn 22, Issue 5, 2002, Pages 270-280

  Trop, Shivti ^a   Ilan, Yaron ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Experimental colitis; NK1.1 T cells; Oral tolerance

Indexed keywords

CELL SURFACE MARKER; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 4; TRINITROBENZENESULFONIC ACID;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HISTOPATHOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFLAMMATION; LIVER; LYMPHOCYTE DEPLETION; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODY FORMATION; BIOLOGICAL MARKERS; COLITIS; CYTOTOXICITY, IMMUNOLOGIC; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; TRINITROBENZENESULFONIC ACID;

EID: 0036748792     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1019974005134     Document Type: Article

References (43)

1. MacDonaland RH: NK1.1+ T cells: New clues to their origin, specificity and function. J Exp Med 182:633-638, 1995
2. Bendelac A: Mouse NK1.1+ T cells. Curr Opin Immunol 7:367-374, 1995
3. Weiner HL: Oral tolerance: Immune mechanisms and treatment of autoimmune diseases. Immunol Today 18:335-343, 1997
4. Strobel S, Mowat AM: Immune response to dietary antigens: Oral tolerance. Immunol Today 4:173-181, 1998
5. Mizoguchi A, Mizoguchi E, Chiba C, Spiekermann GM, Tonegawa S, Anderson CN, Bhan AK: Cytokine imbalance and autoantibody production in T cell receptor-α mutant mice with inflammatory bowel disease. J Exp Med 183:847-856, 1996
6. Strober W, Kelsall B, Fuss L, Marth T, Ludviksson B, Ehrhardt R, Neurath M: Reciprocal IFN-γ and TGF β responses regulate the occurrence of mucosal inflammation. Immunol Today 18:61-64, 1997
7. Neurath M, Kelasall BL, Presky DH, Waegell W, Strober W: Experimental granulomatous colitis in mice is abrogated by induction of TGFβ-mediated oral tolerance. J Exp Med 183:2605-2616, 1996
8. Madsen KL, Lewis Simon A, Tavernini MM, Hibbard J, Fedorak RN: Interleukin 10 prevents cytokine-induced disruption of T84 barrier integrity and limits chloride secretion. Gastroenterology 113:151-159, 1997
9. Van Deventer Sander J, Charles O, Fedorak RN: Multiple doses of intravenous interleukin 10 in steroid refractory Crohn's disease. Gastroenterology, 113:383-389, 1997
10. Ilan Y, Weksler-Zangen S, Ben-Horin S, Diment J, Sauter B, Rabbani E, Engelhardt D, Roy Chowdhury N, Roy Chowdhury J, Goldin E: Treatment of experimental colitis by oral tolerance induction: A central role for suppressor lymphocytes. Am J Gastroenterol 95:966-973, 2000
11. Trop S, Samsonov D, Gotsman I, Alper R, Diment J, Ilan Y: Liver associated lymphocytes expressing NK1.1 are essential for oral tolerance induction in a murine model. Hepatology 29:746-755, 1999
12. Ilan Y, Sauter B, Roy Chowdhury N, Reddy BVN, Thummala NR, Droguett G, Davidson A, Ott M, Horwitz MS, Roy Chowdhury J: Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirus. Hepatology 27:1368-1376, 1998
13. Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V. The NK1.1-mouse: A model to study differentiation of murine NK cells. J Immunol 137:3742-3747, 1988
14. Wynn AT, Reynolds A, James S, Cheever AW, Caspar P, Hieny S, Jankovic D, Strand M, Sher A: IL-12 enhances vaccine-induced immunity to Schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite. J Immunol 157:4068-4078, 1996
15. Crispe N, Mehal WZ. Strange brew: T cells in the liver. Immun Today 11:236-245, 1996
16. Collins C, Norris S, McEntee G, Traynor O, Bruno L, Von Boehmer H, Hegarty J, O'Farrelly C: RAG1, RAG2 and pre-T cell receptor a chain expression by adult human hepatic T cells: Evidence for extrathymic T cell maturation. Eur J Immunol 26:3114-3118, 1996
17. Tsukahara A, Seki S, Liai T, Moroda T, Watanabe H, Suzuki S, Tada T, Hiraide H, Hatakeyama K, Abou T: Mouse liver T cells: Their change with aging and in comparison with peripheral T cells. Hepatology 26:301-311, 1997
18. Arase H, Arase-Fukushi N, Good RA Onoe K: Lymphokine-activated killer cell activity of CD4-CD8-TCRαβ+ thymocytes J Immunol 151:546, 1993
19. Kawamura T, Takeda K, Mendiratta SK, Kawamura H, Van Kaer L, Yagita H, Abo T, Okumura K: Critical role of NK1.1 T cells in IL12-induced immune responses in vivo. J Immunol 160:16-19.
20. Gotsman I, Jurim O, Trop S, Pappo O, Ilan Y: The effect of peripheral immune tolerance induction on liver-associated-lymphocytes expressing NK1.1. Transplant Proc 32:749-750, 2000
21. Samsonov D, Trop S, Alper R, Diment J, Ilan Y:Enhancement of immune tolerance via induction of NK1.1 positive liver-associated-lymphocytes under immunosuppressive conditions in a murine model. J Hepatol 32:812-820, 2000
22. Miller A, Lider O, Roberts AB, Spore M, Weiner HL: Suppressor T cells generated by oral tolerance to myelin basic protein suppress both in vitro and in vivo immune responses by the release of TGFβ following antigen specific triggering. Proc Natl Acad Sci USA 89:421-425, 1992
23. Weiner HL, Mackin GA, Matsui M, Orav EJ, Khoury SJ, Dawson DM, Hafler DA: Double-blind pilot trial of oral tolerization with myelin antigen in multiple sclerosis. Science 261:1321-1324, 1993
24. Von Herrath MG, Dyrberg T, Oldstone MBA: Oral insulin treatment suppresses virus-induced antigen-specific destruction of β cells and prevents autoimmune diabetes in transgenic mice. J Clin Invest 98:1324-1331, 1996
25. Ilan Y, Prakash R, Davidson A, Jona VK, Droguett G, Horwitz MS, Roy Chowdhury N, Roy Chowdhury J: Oral tolerization to adenoviral antigens permits long term gene expression using recombinant adenoviral vectors. J Clin Invest 99:1098-1106, 1997
26. Takahashi M, Ilan Y, Sengupta K, Roy Chowdhury N, Roy Chowdhury J: Induction of tolerance to recombinant adenoviruses by injection into newborn rats: Long term amelioration of hyperbilirubinemia in Gunn rats. J Biol Chem 271:26536-26542, 1996
27. Ilan Y, Jona VK, Sengupta K, Davidson A, Horwitz MS, Roy Chowdhury N, Roy Chowdhury J: Transient immunosuppression with FK506 permits long term expression of therapeutic genes introduced into the liver using recombinant adenoviruses. Hepatology 26:949-956, 1997
28. Ilan Y, Droguett G, Roy Chowdhury N, Yongan L, Sengupta K, Thummala NR, Davidson A, Roy Chowdhury J, Horwitz MS: Insertion of the adenoviral E3 region into a recombinant viral vector prevents antiviral humoral and cellular immune responses and permits long term gene expression. Proc Nat Acad Sci USA 94:2587-2592, 1997
29. Ilan Y, Attavar P, Takahashi M, Davidson A, Horwitz M, Guida J, Roy Chowdhury N, Roy Chowdhury J: Induction of central tolerance by intrathymic inoculation of adenoviral antigens into the host thymus permits long term gene therapy in Gunn rats. J Clin Invest 98:2640-2647, 1996
30. Ilan Y, Roy Chowdhury N, Sauter B, Thummala NR, Horwitz MS, Davidson A, Nakamura J, Fox IJ, Roy Chowdhury J: A critical role of the liver in inducing oral tolerance to adenoviral vectors for long-term gene therapy. Gastroenterology 114:260A, 1998
31. Viola A, Schroder S, Sakakibara Y, Lanzavecchia A: T lymphocyte costimulation by reorganizaion of membrane domains. Science 283:680-682, 1999
32. Doherty DG, Norris S, Collins C, McEntee G, Traynor O, Hegarty J, O'Farrelly C: Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogeneous and include Vα24-JαQ and γδ T cell receptor bearing cells. Human Immunol 60:20-31, 1999
33. Jonsson JR, Edwards-Smith CJ, Morotomi Y, Hogan PG, Clouston AD, Lynch SV, Strong RW, Powell EE: Expression of Fas/FasL and bcl2 in normal human liver derived leukocytes. Hepatology 26:269A, 1997
34. Arase H, Arase N, Kobayashi Y, Nishimura Y, Yonehara S Onoe K: Cytotoxicity of fresh NK1.1 T cells receptor α/β+ thymocytes against a CD4+ CD8+ thymocyte population associated with intact Fas antigen expression on the target. J Exp Med 180:423, 1994
35. Tamada K, Harada M, Abe K. NK1.1+ T cells established from murine tumor-infiltrating lymphocytes. J Immunol 158:4846-4851, 1995
36. Onoe Y, Harada M, Tamada K, Abe K, Li T, Tada H, Nomoto K: Involvement of both donor cytotoxic lymphocytes and host NK1.1+ T cells in the thymic atrophy of mice suffering from acute graft-versus-host disease. Immunology 95:248-256, 1998
37. Neurath MF; Fuss I, Kelsall BL, Stuber E, Strober W: Antibodies to IL-12 abrogate established experimental colitis in mice. J Exp Med 182:1281-1290, 1995
38. Dobashi H, Seki S, Habu Y, Ohkawa T, Takeshita S, Hiraide H, Sekine I: Activation of mouse liver natural killer cells and NK1.1+ T cells by bacterial superantigen-primed Kupffer cells. Hepatology 30:430-436, 1999
39. Siveke JT, Hamann ALF: T helper 1 and T helper 2 cells respond differentially to chemokines. J Immunol 160:550-554, 1998
40. Fernandez NC, Lozier A, Flament C, Ricciardi-Castagnoli P, Bellet D, Suter M, Pericudet M, Tursz T, Marasokovsky E, Zitvogel L: Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5:405-411, 1999
41. Dao T, Mehal WZ, Crispe IN: IL18 augments perforin-dependent cytotoxicity of liver NKT cells. J Immunol 161:2217-2222, 1998
42. Emoto M, Mittrucker HW, Schmits R, Mak TW, Kaufmann SHE: Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+ NKT cells. J Immunol 162:5094-5098, 1999
43. Porceli SA, Brenner MB: Antigen presentation: Mixing oil and water. Curr Biol 7:508-513, 2002